Catalyst Wire Dossier Catalyst Wire Dossier

Busulfan (IV)

busulfan · Varies; Busilvex is a formulation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Busulfan (IV), covering 2017-09-27 to 2017-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old [Phase 3]

See pricing